Raykov Rosty's Form 4 filing
Fennec Pharmaceuticals Inc. (FENC) · filed Apr 5, 2024
- Accession no.
- 0001415889-24-010435
- Filed
- Apr 5, 2024
- Trade date
- Apr 4-5, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $958.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Raykov RostyCIK 0001468316 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2024 | Common shares | SSaleDisposed | −14,583 | $10.89 | −$158,808.87 | 261,471 | Direct | |
| Apr 4, 2024 | Common shares | SSaleDisposed | −29,700 | $10.89 | −$323,433 | 231,771 | Direct | |
| Apr 5, 2024 | Common shares | SSaleDisposed | −44,300 | $10.75 | −$476,225 | 187,471 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.